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ABSTRACT
In a study of university students, the percentage nasal carriage of Staphylococcus aureus was 40.8% 
(102/250). Of the isolates, MIC
50
 of methicillin was 0.5 µg/mL and MIC
90
 was 1 µg/mL. Six (5.8%) 
isolates were methicillin-resistant and carried the mecA gene. These results suggest that community-
associated methicillin-resistant S. aureus may be spreading in Brazil.
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Methicillin-resistant Staphylococcus aureus 
(MRSA) is an important cause of health care-
associated infections worldwide.1 In recent 
years, cases of MRSA infection have been re-
ported more frequently in healthy community 
individuals with no traditional risk factors for 
MRSA infection.2 These infections, apparently 
acquired in the community, are termed com-
munity-associated MRSA infections.2,3
Community-associated MRSA (CA-MRSA) 
strains differ from health care-associated (HA) 
MRSA strains in terms of epidemiology, micro-
biology, and clinical manifestations.3 CA-MR-
SA strains are generally susceptible to most an-
tibiotics, contain staphylococcal chromosome 
cassette mecA type IV, produce the virulence 
factor Panton-Valentine leukocidin, and cause 
mainly skin and soft-tissue infections.2,4
It is well recognized that nasal carriage of 
MRSA represents a major risk factor for sub-
sequent infection and transmission of this 
pathogen.5,6 Although several studies have re-
ported the prevalence of MRSA nasal carriage 
in patients in health care-settings,7,8 this subject 
has been little investigated in healthy individu-
als in the broader community,9 and is practi-
cally unstudied in Brazil.
In this study, we determined the prevalence 
of nasal carriage of S. aureus in university stu-
dents. Antibiotic susceptibility patterns, mini-
mal inhibitory concentration to methicillin, 
and mecA gene detection of the isolates were 
included.
Volunteers – The volunteers were 250 
healthy adults, 93 males and 157 females, in-
cluding fi rst- and second-year undergraduate 
students in pharmacy, nursing, dentistry and 
medicine at a Brazilian university. Their ages 
ranged from 18 to 27 years. After giving their 
written informed consent, the volunteers com-
pleted a questionnaire to obtain demographic 
data and information on risk factors for MRSA 
infection. The study was approved by the Insti-
tutional Review Board of the State University 
of Maringá.
Specimen collection – Each volunteer had 
one nasal specimen collected from the anterior 
nares, with a dry swab (Copan Diagnostics, 
Corona, CA, USA). Swabs were transported 
in Amies medium and processed within 2 h of 
collection. All swabs were collected by the same 
investigator during the study, which was con-
ducted from February to June 2007.
Culture methods – The swab was fi rst in-
oculated directly on mannitol-salt agar (MSA) 
(Difco Laboratories, Sparks, MD, USA). It was 
then placed in a tube containing 10 mL of tryp-
tic soy broth (TSB) (Difco) supplemented with 
7.5% sodium chloride (enrichment broth), 
which was subcultured on MSA after 24 h. In-
oculated plates were screened at 24, 48, and 72 
h for typical colonies of staphylococci. S. au-
reus was identifi ed by colonial morphology, 
Gram stain, and tube coagulase test.
Antimicrobial susceptibility testing - The anti-
microbial susceptibility of S. aureus isolates was 
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assessed by disk-diffusion tests, according to the Clinical 
Laboratory Standards Institute guidelines.10,11 The follow-
ing antimicrobial disks were used: penicillin (10 U), oxacillin 
(1 µg), ciprofloxacin (5 µg), gentamicin (10 µg), ami-
kacin (30 µg), telithromycin (15 µg), linezolid (30 µg), 
trimethoprim-sulfamethoxazole (1.25-23.75 µg), and 
vancomycin (30 µg). All the disks were obtained from 
Oxoid (Oxoid, Basingstoke, UK). A mupirocin (5 µg) 
disk (Oxoid) was also tested, according to Finlay et al. 
(1997).12
Minimal inhibitory concentration (MIC) – MIC to 
oxacillin was assessed by both E-test® oxacillin strips 
(AB-Biodisk, Solna, Sweden) according to the manu-
facturer’s instructions, and the agar dilution method 
as recommended by the Clinical Laboratory Standards 
Institute.11,13
Detection of mecA by polymerase chain reaction (PCR) 
– One hundred and two strains of S. aureus were analyzed 
by PCR assay, using total DNA after boiling the bacte-
rial cells. The mecA gene was detected using mecA sense 
5’TGGCTATCGTGTCACAATCG3’ and mecA antisense 
5’CTGGAACTTGTTGAGCAGAG3’ primers. Cycling pa-
rameters were 94° C for 5 min followed by 30 cycles of 
94° C for 30 sec, annealing at 52° C for 30 sec, extension 
at 72° C for 30 sec, and a final 7 min incubation at 72° 
C. The amplification products (309 bp) were analyzed by 
electrophoresis in 1% agarose gel stained with ethidium 
bromide.
S. aureus was isolated from nasal swabs of 102 (40.8%) 
of the 250 volunteers, and six (2.4%) of them were CA-
MRSA carriers. None of the volunteers had any identi-
fied risk factor.
Recovery of S. aureus strains from volunteers’ nostril 
by direct plating on MSA was 26.8% (67 of 250), and by 
enrichment broth was 40.8% (102 of 250). All the volun-
teers detected as nasal carriers of S. aureus by the MSA 
method, were also detected by the enrichment broth 
method.
All the 102 strains of S. aureus were sensitive to van-
comycin, telithromycin, linezolid, gentamicin, and tri-
methoprim-sulfamethoxazole. Resistance to penicillin 
G, ciprofloxacin, oxacillin, and amikacin was found in 
92.0%, 8.8%, 5.8%, and 4.0% of the strains, respectively. 
Mupirocin resistance was detected in 6 of 102 (5.8%) 
isolates, which were sensitive to oxacillin.
Of the 102 strains, the minimal inhibitory concentra-
tion to oxacillin ranged from 0.06 µg/mL to 256 µg/mL, 
and MIC
50
 and MIC
90
 were 0.5 µg/mL and 1.0 µg/mL, re-
spectively. Six strains (5.88%) showed MIC µ 32 µg/mL 
and carried the mecA gene, and were therefore consid-
ered CA-MRSA. Two CA-MRSA strains were recovered 
only by the enrichment broth method. E-test® and agar 
dilution methods gave similar results.
The prevalence of S. aureus nasal carriage varies ac-
cording to the quality of sampling, culture techniques, 
and the population studied.5,9 Early cross-sectional sur-
veys on nasal carriage demonstrated a mean carriage 
rate of 37.2%.5 More recent studies have reported rates 
of approximately 27% in healthy adult populations.6,14 
Two studies with pre-clinical medical students showed 
that 35.2% and 29% were S. aureus nasal carriers.15,16 Our 
results are consistent with these findings.
Although CA-MRSA emerged as a cause of infection 
in the community in the 1990s, the first report of infec-
tions caused by this microorganism in Brazil was pub-
lished in 2005.17 Our study found the prevalence of CA-
MRSA nasal carriage in our student community to be 
2.4%, which is higher than the findings of similar studies 
by investigators outside Brazil.9,16,18
In cross-sectional studies, the choice of the microbio-
logical method used for S. aureus carriage detection is 
important, because the nasal culture is done only once. 
The enrichment broth method has been recommended to 
increase the sensitivity of detection of MRSA carriage.19 
In our study, two of the six CA-MRSA strains were iso-
lated only by the enrichment broth, and the use of this 
method resulted in improved recovery rates of 14%.
As expected, all the S. aureus isolates, including the 
six CA-MRSA, were susceptible to most of the antimicro-
bial agents tested. Although most of these strains were 
sensitive to oxacillin, their MIC
50
 and MIC
90
 were near 
the resistance breakpoint to oxacillin (i.e., MIC ≥ 4 µg/
mL), suggesting less potency and antimicrobial activity 
of this drug. This finding may be important for develop-
ing therapies for staphylococcal diseases.
In respect to mupirocin, the heavy growth with no 
visible zone of inhibition around the mupirocin disk ob-
served in six S. aureus isolates may indicate a high level 
of resistance (i.e., MIC ≥ 1,024 µg/mL) to this drug.20 
This fact is worrisome because mupirocin is widely used 
for prevention of S. aureus intranasal colonization.1
Our results showed that all strains resistant to oxacillin 
by phenotypic methods carried the mecA gene. This was not 
observed in the oxacillin-sensitive S. aureus strains.
In conclusion, the results of this study showed that 
S. aureus nasal colonization is common in our student 
community, and suggest that CA-MRSA may be spread-
ing in Brazil.
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